Larvol Delta - Merckannounced-the-US-Food-and-Drug-Administration-FDA-has-approved-an-update-to-the-US-product-label-for-WINREVAIR-sotaterceptcsrk-for-injection-45mg-60mg-based-on-the-Phase-3-HYPERION-trial

Winrevair (sotatercept-csrk) - BMS, Merck (MSD)

https://www.merck.com/news/u-s-fda-approves-update-to-the-label-for-winrevair-sotatercept-csrk-to-include-data-from-the-phase-3-hyperion-trial-evaluating-adults-recently-diagnosed-with-pulmonary-arterial-hypertensio/

Sep 22, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next